Bioorganic & Medicinal Chemistry Letters Journal Citation Rate 2026

ISSN 0960-894X eISSN 1464-3405 Elsevier BV GB

Q2 Quartile

About Bioorganic & Medicinal Chemistry Letters
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Bioorganic & Medicinal Chemistry Letters (BMCL) is a peer-reviewed academic journal covering Chemical Synthesis and Analysis and Click Chemistry and Applications, published by Elsevier BV in GB, catalogued under ISSN 0960-894X (e-ISSN 1464-3405). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.91 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model. OpenAlex records 32,747 works and 814,152 citations, with an h-index of 180.

Authors typically receive a first decision in around 62 days.

Bioorganic & Medicinal Chemistry Letters Citation Rate 2026 — In Context

Bioorganic & Medicinal Chemistry Letters has a 2025 2-Year Citation Rate (OpenAlex) of 1.91, placing it in the Q2 quartile within the Chemical Synthesis and Analysis research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Bioorganic & Medicinal Chemistry Letters operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view. Average submission-to-decision turnaround is approximately 62 days.

Researchers looking to publish in Bioorganic & Medicinal Chemistry Letters should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Bioorganic & Medicinal Chemistry Letters against similar journals in the field, use our journal comparison tool.

Submission Tips for Bioorganic & Medicinal Chemistry Letters
  • Be prepared for a longer review cycle — decisions typically take around 62 days.
  • This journal covers Chemical Synthesis and Analysis, Click Chemistry and Applications, Receptor Mechanisms and Signaling. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Bioorganic & Medicinal … Compares
Citation Rate vs Field Avg
-45%
Field avg: 3.48

Compared against 25 journals in the same research areas.

ISSN (Print) 0960-894X
ISSN (Online) 1464-3405
Publisher Elsevier BV
Country United Kingdom
APC / Cost Inquire with Publisher
Review Speed ~62 days to first decision
In-depth profile & metrics

Bioorganic & Medicinal Chemistry Letters is published by Elsevier BV and based in United Kingdom.

In our subject taxonomy, Bioorganic & Medicinal Chemistry Letters is classified under Chemical Synthesis and Analysis, Click Chemistry and Applications, Receptor Mechanisms and Signaling and Synthesis and Biological Evaluation.

For prospective authors, Bioorganic & Medicinal Chemistry Letters returns a first decision in about 62 days (longer for its field).

Its citation rate has risen over the last 2 years, from 1.579 (2023) to 1.912 (2025).

Research Areas
Links
Frequently Asked Questions about Bioorganic & Medicinal Chemistry Letters

Bioorganic & Medicinal Chemistry Letters does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 1.912 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Bioorganic & Medicinal Chemistry Letters is not an open access journal.

The average time from submission to first decision at Bioorganic & Medicinal Chemistry Letters is approximately 62 days.

Bioorganic & Medicinal Chemistry Letters is published by Elsevier BV.

Bioorganic & Medicinal Chemistry Letters is not currently listed in the major indexes we track (Scopus, DOAJ, Web of Science). This is not evidence of predatory practice — many legitimate new or regional journals are not yet indexed — but you should verify its peer-review process, editorial board, and indexing directly with the publisher before submitting.

The ISSN of Bioorganic & Medicinal Chemistry Letters is 0960-894X. Its electronic ISSN (eISSN) is 1464-3405.

Bioorganic & Medicinal Chemistry Letters sits in the Q2 quartile based on its latest impact factor of 1.91, ranked across all journals in our database.
Live Indexing Status
Updated July 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Unverified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
1.912
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend

The impact factor has grown by 21% over the last 2 years (from 1.579 to 1.912), indicating rising influence and citation activity in its field.

Citation Rate by Year
Year Value Source
2025 1.912 2-Year Mean Citedness (OpenAlex)
2023 1.579 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Journal Metrics
62
Days to Decision

Related Journals in Your Field

Metadata

Last updated: Jul 12, 2026

Updated by: system

Get weekly updates for Chemical Synthesis and Analysis journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google